Simoctocog alfa (Nuwiq) clinical trials
Also written Nuwiq.
How each study uses simoctocog alfa (Nuwiq) is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the simoctocog alfa (Nuwiq) studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your saved searches, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your saved searches. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- 22 Jul 2014 · Nuwiq · EMEA/H/C/002813 (EMA)
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
3 studies that test it; most in 2022 (1)
| Year | Studies |
|---|---|
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 1
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 1
Studies that test simoctocog alfa (Nuwiq).
Studies
Open first, then newest update. How each study uses simoctocog alfa (Nuwiq) is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 3
- Nuwiq Dosing and Outcomes In the ManagEment of Women/Girls With Haemophilia A Needing FVIII Treatment for SurgeryRecruitingPhase 4OctapharmaNCT05936580Written as Nuwiq
- Nuwiq for Perioperative Management Of Patients With Haemophilia A on Emicizumab Regular Prophylaxis StudyRecruitingPhase 4OctapharmaNCT05935358Written as Nuwiq
- Emicizumab PUPs and Nuwiq ITI StudyWithdrawnPhase 3Emory UniversityNCT04030052Written as Nuwiq (low dose protocol)
Codes
What other systems call simoctocog alfa (Nuwiq) · ClinicalTrials.gg INT001941
- UNII (FDA) U50VWW6XH6SIMOCTOCOG ALFAConfirmed FDA, Wikidata
- RxNorm 1729084Confirmed FDA, Wikidata
- Wikidata Q22075841simoctocog alfaConfirmed FDA, Wikidata
- NCI Thesaurus C152364Simoctocog AlfaOne source FDA
- DrugBank DB09108One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | U50VWW6XH6 | SIMOCTOCOG ALFA | Confirmed FDA, Wikidata |
| RxNorm | 1729084 | — | Confirmed FDA, Wikidata |
| Wikidata | Q22075841 | simoctocog alfa | Confirmed FDA, Wikidata |
| NCI Thesaurus | C152364 | Simoctocog Alfa | One source FDA |
| DrugBank | DB09108 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.